Last reviewed · How we verify

NCT07090356

Instrument-Assisted Soft Tissue Mobilization Versus PNF Stretching in Athletes With Piriformis Syndrome

Recruiting now NA Last updated 29 July 2025
What this trial tests

NA trial testing Instrument-Assisted Soft Tissue Mobilization in Piriformis Syndrome in 40 participants. Currently enrolling.

Timeline
30 July 2024
Primary endpoint
30 July 2025
30 August 2025

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date30 July 2024
Primary completion30 July 2025
Estimated completion30 August 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 18 to 35, any sex, with Piriformis Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A 12-month randomized controlled trial will be conducted at Pakistan Sports Board, Lahore, with 40 athletes (18-35 years) randomly allocated to IASTM (n=20) or PNF (n=20) groups. Interventions were administered 3 times/week for 4 weeks. Outcomes included Numeric Pain Rating Scale (NPRS), goniometric hip ROM, and Oswestry Disability Index (ODI).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Instrument-Assisted Soft Tissue Mobilization

Trials testing the same drug.

Other recruiting trials for Piriformis Syndrome

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07090356.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing